What is the recommended dose of terlipressin for variceal bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Terlipressin Dosing for Variceal Bleeding

The recommended dose of terlipressin for variceal bleeding is 2 mg IV every 4 hours for the initial 48 hours until bleeding is controlled, followed by a maintenance dose of 1 mg IV every 4 hours for 2-5 days to prevent rebleeding. 1, 2

Dosing Regimen Details

  • Initial phase (first 48 hours):

    • 2 mg IV every 4 hours until bleeding is controlled
  • Maintenance phase:

    • 1 mg IV every 4 hours to prevent rebleeding
    • Continue for 2-5 days total duration
  • Treatment duration considerations:

    • Standard duration: 2-5 days
    • May consider shorter course (24-72 hours) in selected patients with:
      • Child-Pugh A or B cirrhosis
      • No active bleeding during endoscopy
      • Successful endoscopic variceal ligation 2, 3

Administration Options

  • Traditional method: Intravenous bolus injections as described above
  • Alternative method: Continuous infusion at 4 mg/24 hours
    • Recent evidence suggests continuous infusion may be more effective at reducing portal pressure with fewer adverse events and at a lower total daily dose 4
    • Continuous infusion resulted in better HVPG response rates (85.4% vs 58.2%) compared to bolus dosing 4

Clinical Considerations

  • Terlipressin should be started as soon as variceal bleeding is suspected, before diagnostic endoscopy 1
  • Should be administered alongside prophylactic antibiotics 1
  • Only one vasoactive agent should be used at a time 1
  • Terlipressin has similar efficacy to somatostatin and octreotide in controlling acute variceal hemorrhage 1

Monitoring During Treatment

  • Monitor for adverse effects:
    • Oxygen saturation (continuous pulse oximetry recommended)
    • Serum sodium levels
    • Signs of cardiac ischemia
    • Renal function 2

Important Precautions

  • Contraindications:

    • Hypoxemia (SpO₂ <90%)
    • Ongoing coronary, peripheral, or mesenteric ischemia 2
    • Use with caution in patients with acute-on-chronic liver failure grade 3 2
  • Common adverse effects:

    • Hyponatremia
    • Myocardial ischemia
    • Abdominal pain
    • Diarrhea
    • Hypoxemia 2

Treatment Algorithm

  1. Start terlipressin at first suspicion of variceal bleeding
  2. Initial dose: 2 mg IV every 4 hours
  3. Perform endoscopy within 12 hours
  4. After bleeding control:
    • Continue at 1 mg IV every 4 hours
  5. Assess patient's Child-Pugh score and bleeding status:
    • For Child-Pugh A/B with no active bleeding: Consider shorter course (2 days)
    • For Child-Pugh C or active bleeding: Continue for full 5-day course
  6. Discontinue if SpO₂ <90% or signs of ischemia develop

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.